Single-Digit Restenosis Rates Justify Coated Stent Price Premium - Guidant

Guidant expects its paclitaxel-coated stent agreement with Cook, Inc. to yield at least a $1,000 price premium over conventional coronary stents in the U.S.

More from Archive

More from Medtech Insight